Table 1.
Key care elements in the chronic obstructive pulmonary disease (COPD) care pathways program.
Fig 1.
COPD: chronic obstructive pulmonary disease. FY: fiscal year.
Table 2.
Comparison of baseline characteristics between treatment and control subjects in the unmatched and matched samples.
Table 3.
Results of the cost-effectiveness analyses for the entire sample and for the manually defined subgroups of Charlson comorbidity index, age, and sex.
Fig 2.
Cost-effectiveness plane and cost-effectiveness acceptability curve for the entire sample.
COPD: chronic obstructive pulmonary disease. WTP: willingness to pay.
Fig 3.
Cost-effectiveness planes, by manually defined subgroups of Charlson comorbidity index, age, and sex.
COPD: chronic obstructive pulmonary disease. WTP: willingness to pay.
Fig 4.
Cost-effectiveness acceptability curves, by manually defined subgroups of (a) Charlson comorbidity index, (b) age, and (c) sex. COPD: chronic obstructive pulmonary disease.
Fig 5.
Targeted treatment policies suggested by automated policy learning.
COPD: chronic obstructive pulmonary disease.
Table 4.
Estimates of the expected welfare gain from implementing targeted treatment policies.